Harnessing Beneficial AGI to Decentralise Diagnosis & Healthcare
access to highest-quality population clinical data + unique remote continuous monitoring technology + proprietary predictive Artificial Superintelligence
OIA’s expertise in AI is directed towards solving some of the most pressing challenges of the human condition, from antibiotic resistance and chronic inflammation to cancer, by leveraging lifelong clinical data from over 60 million individuals to extend healthy human lifespans.
Algocyte®, OIA’s flagship end-to-end platform, enables remote and personal diagnostic endpoints across healthcare pathways—from lab to home and from home to hospital—through regular blood monitoring, which drives or informs around 70% of all medical diagnoses.
By combining objective clinical data with subjective lifestyle and personal event data, Algocyte delivers a continuous, intelligent view of human health that bridges precision medicine and everyday life.
Today, healthcare remains centralised in hospitals and clinics. At Oxford Immune Algorithmics (OIA), we are developing Beneficial Artificial Superintelligence (ASI) to decentralise healthcare — delivering precision diagnostics and predictive medicine directly into people’s homes through continuous digital health and immune monitoring.
Incubated and accelerated by the Universities of Oxford and Cambridge (Oxbridge) and later spun out from King’s College London, OIA brings together leading research in computational biology, artificial intelligence, and medical data science.
We are the creators and scientists behind several widely used AI technologies, including some of the early innovations that underpin today’s frontier systems—from Siri and Alexa to ChatGPT—originating in our founder’s early work on computational linguistics and symbolic inference as part of the original development team of Wolfram|Alpha, a pioneering engine for predictive computational intelligence.
= equal access to highest-quality healthcare for everyone, everywhere
60m+
Access to
enriched patient lifelong records from NHS clinical data
250k
Proprietary
highly accurate labelled repository of normal and pathological single-cell images for AI training purposes
100+
Published
peer-reviewed high-impact research papers
validating OIA’s science + 2 patents granted in the US
Access to
125m+
blood test results
1tn+
Proprietary
causal mechanistic, explainable, and interpretable computable models and testable scientific hypotheses for disease progression
Won
multiple
innovation & AI prizes beating companies such as Microsoft, Accenture, and Etihad in international competitions
Fully sponsored and produced by the highest-impact scientific journal, Nature, this video, based on our peer-reviewed publication in the same journal, explains OIA’s causal and model-driven approach to Super Intelligence
Algocyte’s universal input devices
Fully end-to-end automated portable lab to monitor people’s health at home, from anaemia to infection to cancer to auto immune diseases
Data collection: Capable of ingesting multiple data streams from multiple types of data-generating and testing IoT devices
Collects & deals with multiple sources of clinical, biological and lifestyle data cross referencing one against each other
An open platform on which commercial & academic solutions can be developed and deployed by software and reagent updates based on light, spectral and immunofluorescence microscopy
Automation tools for classification and triaging of users and patients
AI at bedside care that enables detection of early signals for better and faster clinical responses
Can monitor & learn from users over time to support clinical pathways and predictive medicine
Advanced AI-reasoning & predictive capabilities for remote care and precision healthcare
Finds prescription gaps to support governments and life science companies to implement predictive population health management strategies
Algocyte® can help understand the dynamics of health and disease, find prescription gaps, complement at-home therapeutic solutions, enable home-driven precision medicine, and manage remote predictive care
Generative ASI diagnostics
Leading AI-driven solutions built using symbolic regressive and predictive Artificial General Intelligence are causal model-driven.
OIA’s Proprietary technology is based on years of research at Oxford, Cambridge, King’s College London, and the Karolinska Institute, which awards the Nobel Prize in Physiology or Medicine.
The AI Hospital of the future built on 3 key pillars
Algocyte® is an AGI precision diagnostics platform providing proprietary quantitative risk assessment scores
Quantitative Precision
Prediction, Prevention and Early Detection
Professionals can analyse users’ results relative to personalised norms, triage, and flag concerning trends
Individualised Learning and Monitoring
The Algocyte® platform learns from each user based on a digital twin baseline and builds their personal profile allowing forecasting, prediction or diagnosing
Want to find out more?
In our downloadable PDF, we share the in-depth science behind our breakthrough product. Delve into the specifics of our leading precision & predictive platform.